Quality control of protein crystal suspensions using microflow imaging and flow cytometry.
暂无分享,去创建一个
[1] Roman Mathaes,et al. Application of different analytical methods for the characterization of non-spherical micro- and nanoparticles. , 2013, International journal of pharmaceutics.
[2] Henryk Mach,et al. The use of flow cytometry for the detection of subvisible particles in therapeutic protein formulations. , 2011, Journal of pharmaceutical sciences.
[3] Theodore W Randolph,et al. Flow cytometry: a promising technique for the study of silicone oil-induced particulate formation in protein formulations. , 2011, Analytical biochemistry.
[4] S. Singh,et al. An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. , 2010, Journal of pharmaceutical sciences.
[5] M. Groves,et al. A method for the general identification of protein crystals in crystallization experiments using a noncovalent fluorescent dye. , 2007, Acta crystallographica. Section D, Biological crystallography.
[6] Alexander McPherson,et al. Introduction to protein crystallization. , 2004, Methods.
[7] A. Margolin,et al. Injectable controlled release formulations incorporating protein crystals. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[8] A. Margolin,et al. Protein crystals for the delivery of biopharmaceuticals , 2004, Expert opinion on biological therapy.
[9] Sergey Pechenov,et al. Crystalline monoclonal antibodies for subcutaneous delivery , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[10] H. Merkle,et al. Diamonds in the rough: protein crystals from a formulation perspective. , 2001 .
[11] B. Shenoy,et al. Stability of crystalline proteins. , 2001, Biotechnology and bioengineering.
[12] J. Vermant,et al. Rheooptical determination of aspect ratio and polydispersity of nonspherical particles , 2001 .
[13] S. Frokjaer,et al. Pharmaceutical Formulation Development Of Peptides And Proteins , 2009 .